Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey.
Journal
European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966
Informations de publication
Date de publication:
01 04 2022
01 04 2022
Historique:
pubmed:
23
12
2021
medline:
6
4
2022
entrez:
22
12
2021
Statut:
ppublish
Résumé
The coronavirus disease COVID-19 pandemic posed a number of challenges to the oncology community, particularly the diagnosis and care of cancer patients while ensuring safety from the virus for both patients and professionals: minimization of visits to the hospital, cancellation of the screening programmes and the difficulties in the management and operation of cancer registries (CRs) while working remotely. This article describes the effects in the medium term of the first wave of the COVID-19 pandemic on cancer registration in Europe, focusing on changes in cancer detection and treatment, possible reduction of CR resources and difficulties in the access to data sources. A questionnaire was distributed in June 2020 to the directors of 108 CRs from 34 countries affiliated to the European Network of Cancer Registries, providing a 37% response rate. The results of the survey showed that cancer-screening programmes were mostly stopped or slowed down in the majority of regions covered by the respondent CRs. Cancer diagnostics and treatments were severely disrupted. The cancer registration process was also disrupted, due to changes in the work modalities for the personnel, as well as to the difficulties in accessing sources and/or receiving the notifications. In some CRs, staff was allocated to different activities related to controlling the pandemic. Several CRs reported that they were investigating the impact of COVID-19 on cancer care via dedicated studies. A careful analysis will be necessary for proper interpretation of temporal and geographical variations of the 2020 cancer burden indicators.
Sections du résumé
BACKGROUND
The coronavirus disease COVID-19 pandemic posed a number of challenges to the oncology community, particularly the diagnosis and care of cancer patients while ensuring safety from the virus for both patients and professionals: minimization of visits to the hospital, cancellation of the screening programmes and the difficulties in the management and operation of cancer registries (CRs) while working remotely. This article describes the effects in the medium term of the first wave of the COVID-19 pandemic on cancer registration in Europe, focusing on changes in cancer detection and treatment, possible reduction of CR resources and difficulties in the access to data sources.
METHODS
A questionnaire was distributed in June 2020 to the directors of 108 CRs from 34 countries affiliated to the European Network of Cancer Registries, providing a 37% response rate.
RESULTS
The results of the survey showed that cancer-screening programmes were mostly stopped or slowed down in the majority of regions covered by the respondent CRs. Cancer diagnostics and treatments were severely disrupted. The cancer registration process was also disrupted, due to changes in the work modalities for the personnel, as well as to the difficulties in accessing sources and/or receiving the notifications. In some CRs, staff was allocated to different activities related to controlling the pandemic. Several CRs reported that they were investigating the impact of COVID-19 on cancer care via dedicated studies.
CONCLUSIONS
A careful analysis will be necessary for proper interpretation of temporal and geographical variations of the 2020 cancer burden indicators.
Identifiants
pubmed: 34935934
pii: 6478278
doi: 10.1093/eurpub/ckab214
pmc: PMC8975538
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
311-315Investigateurs
Anna Gavin
(A)
Otto Visser
(O)
María José Sánchez
(MJ)
Michael Eden
(M)
Fabrizio Stracci
(F)
Mario Šekerija
(M)
Maciej Trojanowski
(M)
Freddie Bray
(F)
Elizabeth van Eycken
(E)
Ana Miranda
(A)
Hans Storm
(H)
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Public Health Association.
Références
Acta Oncol. 2021 Jan;60(1):20-23
pubmed: 33287604
Int J Cancer. 2022 Jan 15;150(2):273-278
pubmed: 34480348
Gastroenterology. 2020 Dec;159(6):1998-2003
pubmed: 32966824
Rep Pract Oncol Radiother. 2020 Sep-Oct;25(5):820-827
pubmed: 32837336
Lancet Oncol. 2021 Mar;22(3):309-320
pubmed: 33493433
Gastroenterology. 2021 May;160(6):2169-2171.e1
pubmed: 33513406
Eur J Cancer. 2021 Nov;157:308-347
pubmed: 34560371
Radiol Oncol. 2020 Jul 29;54(3):329-334
pubmed: 32726291
Lancet Oncol. 2020 Jun;21(6):750-751
pubmed: 32359403
Br J Cancer. 2021 Sep;125(6):798-805
pubmed: 34211120
Int J Cancer. 2021 Jul 15;149(2):287-296
pubmed: 33634852
Acta Paediatr. 2021 Sep;110(9):2529-2535
pubmed: 34028088